Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2082366 | Drug Discovery Today: Disease Models | 2013 | 6 Pages |
Abstract
MicroRNAs (miRNAs) are a novel class of post-transcriptional regulators. In vitro studies suggest that a single miR can mediate profound effects on a variety of cellular activities ranging from cell cycle, motility and metabolism to effector function. This is facilitated by the capacity of miRNA to modulate several pathways by virtue of binding to multiple target mRNAs – which renders them attractive potential therapeutic targets. Several miRNAs are now implicated in regulating pathogenesis related cellular subsets in both clinical and experimental arthritis. The therapeutic potential of such observations will be discussed here, with particular emphasis given to the context of experimental arthritis models.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Clare Tange, Iain B. McInnes, Mariola Kurowska-Stolarska,